Shannon Elaine Slizoski, LMFT | |
703 W Canal St, Picayune, MS 39466-3918 | |
(601) 590-1580 | |
Not Available |
Full Name | Shannon Elaine Slizoski |
---|---|
Gender | Female |
Speciality | Marriage & Family Therapist |
Location | 703 W Canal St, Picayune, Mississippi |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1053672394 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
106H00000X | Marriage & Family Therapist | T0453 (Mississippi) | Primary |
Mailing Address | Practice Location Address |
---|---|
Shannon Elaine Slizoski, LMFT 703 W Canal St, Picayune, MS 39466-3918 Ph: (601) 590-1580 | Shannon Elaine Slizoski, LMFT 703 W Canal St, Picayune, MS 39466-3918 Ph: (601) 590-1580 |
News Archive
The childhood obesity epidemic in the United States has been growing for decades. A new study focusing on African-American children shows how the issue can also impact social development. The University of Cincinnati study led by Laura Nabors, an associate professor of health promotion and education, will be featured in a poster presentation on Nov. 2, at the 143rd American Public Health Association Annual Meeting and Expo, in Chicago.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, today announced The 2013 AEIRS/Elsevier Innovator of the Year Award recipients. Mahsa Dehghanpour, EDd, MS, CMD, Program Director and Assistant Professor, and Jamie Baker, MEd, CMD, Instructor and Education Coordinator, both of the Medical Dosimetry Program at the University of Texas MD Anderson Cancer Center School of Health Professions (SHP), have been recognized for their outstanding work as educators in imaging sciences.
India has become the "premier drug provider for the developing world" by producing generic versions of some of the world's most effective medicines, including antiretroviral drugs, but the country's decision to adhere to international patent regulations could limit access to generic drugs in the developing world, the Christian Science Monitor reports.
Patients who suffer from thrombosis, pulmonary embolism or stroke are usually put on drugs that help their blood flow more smoothly through their body.
› Verified 7 days ago